National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1053462

Government Disclaimer on use of this data

History of Changes from the VAERS Wayback Machine

First Appeared on 7/2/2021

VAERS ID: 1053462
VAERS Form:2
Age:32.0
Sex:Female
Location:Foreign
Vaccinated:2021-01-06
Onset:0000-00-00
Submitted:0000-00-00
Entered:2021-02-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EL0141 / UNK - / -

Administered by: Other      Purchased by: ??
Symptoms: Abortion spontaneous, Headache, Pain in extremity, Pregnancy test, Human chorionic gonadotropin, Maternal exposure during pregnancy, SARS-CoV-2 test

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: FOLIC ACID
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Folic acid supplementation
Allergies:
Diagnostic Lab Data: Test Name: Blood hcg; Result Unstructured Data: Test Result:Blood hcg showed early miscarriage; Test Name: pregnancy test; Test Result: Positive ; Test Name: COVID-19; Result Unstructured Data: Test Result:No - Negative COVID-19 test
CDC 'Split Type': GBPFIZER INC2021147303

Write-up: Maternal exposure during pregnancy; Early miscarriage; Headache; Painful arm; This is a spontaneous report from a consumer or other non hcp. This is a report received from the Regulatory Agency (RA). Regulatory authority report number GB-MHRA-WEBCOVID-202102100805410190. Safety Report Unique Identifier GB-MHRA-ADR 24731748. A 32-year-old female patient started to receive BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL0141), via an unspecified route of administration, on 06Jan2021 at SINGLE DOSE for covid-19 immunisation. Medical history included folic acid supplementation. Concomitant medication included folic acid for Folic acid supplementation. The patient experienced maternal exposure during pregnancy, early miscarriage, headache and painful arm on an unspecified date. The events were assessed as medically significant by the reporter. The mother reported she became pregnant while taking bnt162b2. Patient was exposed to the medicine first-trimester (1-12 weeks). The patient underwent lab tests and procedures which included Blood hcg: blood hcg showed early miscarriage, pregnancy test: positive and COVID-19: no - negative covid-19 test on unspecified date. Outcome of the event early miscarriage was recovered with sequelae while outcome of the events painful arm and headache was recovered on an unspecified date. Outcome of the remaining event was unknown. No follow-up attempts are possible. No further information is expected.

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1053462&WAYBACKHISTORY=ON


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166